E-LIB Suche - Ergebnisse für: Kaslow, David C.

1

Accelerating access for all through research and innovation..:

Sarley, David ; Hwang, Angela ; Fenton Hall, B....
Vaccine. 42 (2024) - p. S82-S90 , 2024

Link: https://doi.org/10.1016/..

2

Realising the potential of correlates of protection for vac..:

King, Deborah F. ; Groves, Helen ; Weller, Charlie...
npj Vaccines. 9 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

3

Clinical and regulatory development strategies for Shigella..:

Giersing, Birgitte K ; Isbrucker, Richard ; Kaslow, David C...
The Lancet Global Health. 11 (2023) 11 - p. e1819-e1826 , 2023

Link: https://doi.org/10.1016/..

4

Who to vaccinate first? A peek at decision-making in a pand..:

Faden, Ruth ; Cravioto, Alejandro ; Hombach, Joachim...
Nature. 607 (2022) 7918 - p. 235-238 , 2022

Link: https://doi.org/10.1038/..

5

Response to additional COVID-19 vaccine doses in people who..:

Parker, Edward P K ; Desai, Shalini ; Marti, Melanie...
The Lancet Global Health. 10 (2022) 3 - p. e326-e328 , 2022

Link: https://doi.org/10.1016/..

6

Standardization of Epidemiological Surveillance of Group A ..:

Miller, Kate M ; Tanz, Robert R ; Shulman, Stanford T...
Open Forum Infectious Diseases. 9 (2022) Supplement_1 - p. S5-S14 , 2022

Link: https://doi.org/10.1093/..

7

KSHV (HHV8) vaccine: promises and potential pitfalls for a ..:

Casper, Corey ; Corey, Lawrence ; Cohen, Jeffrey I....
npj Vaccines. 7 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

8

Understanding the public health value and defining preferre..:

Prudden, Holly J. ; Achilles, Sharon L. ; Schocken, Celina...
Vaccine. 40 (2022) 41 - p. 5843-5855 , 2022

Link: https://doi.org/10.1016/..

9

Leveraging mRNA Platform Technology to Accelerate Developme..:

Sparrow, Erin ; Hasso-Agopsowicz, Mateusz ; Kaslow, David C....
Frontiers in Tropical Diseases. 3 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

10

Standardization of Epidemiological Surveillance of Acute Po..:

Miller, Kate M ; Van Beneden, Chris ; McDonald, Malcolm...
Open Forum Infectious Diseases. 9 (2022) Supplement_1 - p. S57-S64 , 2022

Link: https://doi.org/10.1093/..

11

Building the concept for WHO Evidence Considerations for Va..:

Kochhar, Sonali ; Barreira, Draurio ; Beattie, Pauline...
Vaccine. 40 (2022) 12 - p. 1681-1690 , 2022

Link: https://doi.org/10.1016/..

12

Standardization of Epidemiological Surveillance of Group A ..:

Miller, Kate M ; Lamagni, Theresa ; Hay, Roderick...
Open Forum Infectious Diseases. 9 (2022) Supplement_1 - p. S25-S30 , 2022

Link: https://doi.org/10.1093/..

13

WHO preferred product characteristics for monoclonal antibo..:

Sparrow, Erin ; Adetifa, Ifedayo ; Chaiyakunapruk, Nathorn...
Vaccine. 40 (2022) 26 - p. 3506-3510 , 2022

Link: https://doi.org/10.1016/..

14

A Systematic Framework for Prioritizing Burden of Disease D..:

Moore, Hannah C ; Cannon, Jeffrey W ; Kaslow, David C...
Clinical Infectious Diseases. 75 (2022) 7 - p. 1245-1254 , 2022

Link: https://doi.org/10.1093/..

15

Standardization of Epidemiological Surveillance of Invasive..:

Miller, Kate M ; Lamagni, Theresa ; Cherian, Thomas...
Open Forum Infectious Diseases. 9 (2022) Supplement_1 - p. S31-S40 , 2022

Link: https://doi.org/10.1093/..